HEADACHE/MIGRAINE

NeurologyLive's Headache & Migraine Clinical Focus page focuses on the latest news, research, and FDA approvals for migraines and headaches.

Comment from Sean Brynjelsen, MBA, MS

Topiramate Oral Solution ET-101 Shows Bioequivalence With Topamax

Eton Pharmaceuticals plans to submit a new drug application for ET-101 in the third quarter of 2020, anticipating its formulation to be the first approved oral topiramate solution.

FDA Approves Intranasal Diazepam, Rimegepant and Erenumab Effectively Treats Refractory Migraine, MS Treatments Double Since 2011

Neurology News Network for the week ending January 18, 2020.

Webinar: Outpatient Telemedicine Billing and Coding in the Age of COVID-19

The webinar, a partnership between Women Neurologist's Group (WNG) and NeurologyLive, features the latest updates from CMS on billing and coding for telemedicine visits.

Triptan Refills for Migraine Treatment Decrease Over Time

Patients opted for nontriptan acute medications such as opioids and nonsteroidal anti-inflammatory drugs instead of staying on triptans at 12- and 24-month follow-ups.

COVID-19: Protecting Health Care Workers During the Coronavirus Pandemic

As neurologists and other specialists may increasingly be called upon to serve as general hospitalists in the wake of the COVID-19 pandemic, keeping health care workers healthy becomes paramount.

New Neuroimaging Guidelines for Migraine, Lemborexant Improves Sleep Onset, Patients with Parkinsons Have Compromised Swimming Ability

Ubrogepant Provides Pain Relief for Acute Migraine, Cenobamate Reduces Focal-onset Seizures, Valbenazine Decreases Involuntary Movements in Patients with Tardive Dyskinesia

Mia Minen, MD, MPH: Behavioral Therapies for Posttraumatic Headache

Previous Page Next Page

About NeurologyLive's Headache & Migraine Clinical Focus page:

The NeurologyLive Headache & Migraine Clinical Focus page serves as a hub for breaking news, videos, and other resources. Items covered here include updates from the most-attended neurological conferences and annual meetings via articles and video interviews with neurology’s leading experts and key opinion leaders.

This page will always be up-to-date, providing breaking news coverage of U.S. Food and Drug Administration (FDA) approvals, key takeaways from the latest clinical trials, and notifications of recent updates to clinical guidelines for headaches and migraines. Additionally, this Clinical Focus page provides an array of condition-specific resources, like information on new and emerging therapies for migraine relief and prevention.